Regeneron Pharmaceuticals Inc. buy Evercore ISI
Start price
16.05.24
/
50%
€899.00
Target price
16.05.25
-
Performance (%)
-41.09%
End price
17.05.25
€529.60
Summary
This prediction ended on 17.05.25 with a price of €529.60. The BUY prediction by Evercore_ISI for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -41.09%. A total of €0.84 was paid as dividends for this prediction. Evercore_ISI has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.927% | -1.927% | -7.153% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Evercore_ISI for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Evercore_ISI for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€859.80
24.10.24
24.10.24
€1,087.7
24.10.25
24.10.25
-42.02%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€909.80
14.05.24
14.05.24
€1,064.2
14.05.25
14.05.25
-43.88%
15.05.25
15.05.25